Dimensional Fund Advisors
PRME icon

Dimensional Fund Advisors’s Prime Medicine PRME Stock Holding History

Dimensional Fund Advisors’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
304,522
+220,468
+262% +$839K ﹤0.01% 2831
2025
Q4 		$292K Buy
+84,054
New +$374K ﹤0.01% 3047

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Dimensional Fund Advisors's PRME Position: Q1 2026 in Review

Dimensional Fund Advisors increased its Prime Medicine (PRME) stake by 262% in Q1 2026, buying an estimated $839K and bringing the position to 304,522 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2831.

Dimensional Fund Advisors first reported a position in PRME in Q4 2025 and has held it in 2 quarters since. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Dimensional Fund Advisors held 304,522 shares of Prime Medicine worth $1.06M as of Q1 2026.
  • Dimensional Fund Advisors bought 220,468 Prime Medicine shares in Q1 2026, an estimated $839K.
  • Prime Medicine made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2831 holding.
  • Dimensional Fund Advisors first reported a position in Prime Medicine in Q4 2025 and has held it in 2 quarters since.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.